+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of arteriosclerosis

Treatment of arteriosclerosis

Official Gazette of the United States Patent & Trademark Office Patents 1257(1), Apr 2

A method is disclosed of treating transplant-associated arteriosclerosis in a mammal which comprises administering to a mammal, preferably man, in need of such treatment an effective amount of a VLA-4 antagonist of formula I and a VCAM-1 inhibitor of formula II.

(PDF same-day service: $19.90)

Accession: 035980996

Download citation: RISBibTeXText

DOI: 10.1001/jama.1905.02510250043013

Related references

CLINICAL pathologic conference: diabetes mellitus with complications, including generalized arteriosclerosis, cerebral arteriosclerosis, coronary arteriosclerosis, hypertensive cardiovascular disease and arteriosclerosis obliterans of the extremities. Journal. Iowa State Medical Society 42(10): 497-502, 1952

Polyunsaturated phosphatidyl choline (EPL) in the treatment of cerebral arteriosclerosis and arteriosclerosis of the lower extremities. La Clinica Terapeutica 74(1): 55-62, 1975

Symposium: Arteriosclerosis (with special reference to thrombosis and anticoagulants). 3. Coronary arteriosclerosis and anticoagulant treatment. Japanese Journal of Medical Science & Biology 51: 857-863, 1962

Surgical treatment of arteriosclerosis; the challenge of arteriosclerosis to surgeons. Minnesota Medicine 38(12): 902-903, 1955

Studies of thrombophilic syndromes. I. Coagulation changes in coronary arteriosclerosis, cerebral arteriosclerosis and peripheral artery arteriosclerosis. Rivista Critica di Clinica Medica 68(3): 211-237, 1968

Modern concepts on arteriosclerosis; arteriosclerosis and atherosclerosis, arteriosclerosis senility, nephrosclerosis, coronary sclerosis. Revista de Medicina Y Ciencias Afines 10(112): 115-132, 1951

Experimental arteriosclerosis in the lungs, especially on research by reconstructing model 5 Comparative research for pulmonic arteriosclerosis of human body and various kinds of experimental arteriosclerosis. 1950

Principle of treatment of intermittent claudication due to arteriosclerosis obliterans--reconstruction or conservative treatment. Nihon Geka Gakkai Zasshi 93(9): 1040-1042, 1992

Role of the altered transmural permeability in the pathomechanism of arteriosclerosis. History of arteriosclerosis theories. Role of the altered permeability in experimental arteriosclerosis models. Pathology, Research and Practice 181(6): 693-712, 1986

Experiment on a causal therapy of arteriosclerosis with a combination of hyaluronidase and magnesium. 8. On the arteriosclerosis problem. Schweizerische Medizinische Wochenschrift 92: 949-956, 1962

Symposium: Arteriosclerosis (with special reference to thrombosis and anticoagulants). 2. Significance of plasmin in arteriosclerosis. Japanese Journal of Medical Science & Biology 51: 850-856, 1962

Arteriosclerosis in industrial medicine; arteriosclerosis caused by physical work and technic substances. Folia Medica. Folia Medica 39(6): 573-603, 1956

Pathogenesis of experimental arteriosclerosis in pyridoxine deficiency; with notes on similarities to human arteriosclerosis. A.M.A. Archives of Pathology 51(1): 12-18, 1951

Congenital arteriosclerosis of the pulmonary artery The importance of the time factor in the genesis of arteriosclerosis. 1963

Biochemical principles of early diagnosis of arteriosclerosis. I. behavior of blood lipids in arteriosclerosis. Polski Tygodnik Lekarski 13(19): 701-705, 1958